Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


25.11.2019

1 BMJ
6 J Infect Dis
10 J Virol
1 JAMA
1 Lancet
1 MMWR Morb Mortal Wkly Rep
1 Pediatr Infect Dis J
3 Pediatrics
1 PLoS One
8 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. TORJESEN I
    The Daily Mail's U turn on MMR vaccination.
    BMJ. 2019;367:l6487.
    PubMed     Text format    


    J Infect Dis

  2. PUKSURIWONG S, Ahmed MS, Sharma R, Krishnan M, et al
    MVA-NP+M1 vaccine activates mucosal M1-specific T cell immunity and tissue-resident memory T cells in human nasopharynx-associated lymphoid tissue.
    J Infect Dis. 2019 Nov 19. pii: 5628940. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. ENDY TP, Keiser PB, Cibula D, Abbott M, et al
    Effect of Antimalarial Drugs on the Immune Response to Intramuscular Rabies Vaccination Using a Postexposure Prophylaxis Regimen.
    J Infect Dis. 2019 Nov 2. pii: 5611063. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. KEITEL WA, Atmar RL
    Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
    J Infect Dis. 2019 Nov 20. pii: 5634378. doi: 10.1093.
    PubMed     Text format    

  5. BEALL B, Van Beneden C
    Challenges to vaccine development-the diversity of group A streptococcal strains among varied climates and global regions.
    J Infect Dis. 2019 Nov 21. pii: 5636891. doi: 10.1093.
    PubMed     Text format    

  6. LO MK, Spengler JR, Welch SR, Harmon JR, et al
    Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
    J Infect Dis. 2019 Nov 21. pii: 5637464. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. GLASS A, Polhemus M, Wang D, Jarman RG, et al
    The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine (CYD-TDV): A Phase II, Randomized, Open-label, Single Center Trial in Adults Aged 18 t
    J Infect Dis. 2019 Nov 22. pii: 5637716. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  8. CHEA LS, Wyatt LS, Gangadhara S, Moss B, et al
    Novel MVA Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses.
    J Virol. 2018 Dec 12. pii: JVI.01648-18. doi: 10.1128/JVI.01648.
    PubMed     Text format     Abstract available

  9. GROSS DA, Ghenassia A, Bartolo L, Urbain D, et al
    Cross-Presentation of Skin-Targeted Recombinant Adeno-associated Virus 2/1 Transgene Induces Potent Resident Memory CD8(+) T Cell Responses.
    J Virol. 2019;93.
    PubMed     Text format     Abstract available

  10. WANG H, Wong G, Zhu W, He S, et al
    Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease.
    J Virol. 2019;93.
    PubMed     Text format     Abstract available

  11. KESHWARA R, Hagen KR, Abreu-Mota T, Papaneri AB, et al
    A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein is Dependent Upon ADCC for Protection Against Marburg Virus Disease in a Murine Model.
    J Virol. 2018 Dec 19. pii: JVI.01865-18. doi: 10.1128/JVI.01865.
    PubMed     Text format     Abstract available

  12. OBADAN AO, Santos J, Ferreri L, Thompson AJ, et al
    Flexibility in vitro of amino acid 226 in the receptor-binding site of an H9 subtype influenza A virus and its effect in vivo on virus replication, tropism, and transmission.
    J Virol. 2018 Dec 19. pii: JVI.02011-18. doi: 10.1128/JVI.02011.
    PubMed     Text format     Abstract available

  13. ARUNKUMAR GA, Ioannou A, Wohlbold TJ, Meade P, et al
    Broadly cross-reactive, non-neutralizing antibodies against the influenza B virus hemagglutinin demonstrate effector function dependent protection against lethal viral challenge in mice.
    J Virol. 2019 Jan 9. pii: JVI.01696-18. doi: 10.1128/JVI.01696.
    PubMed     Text format     Abstract available

  14. LI ZT, Zarnitsyna VI, Lowen AC, Weissman D, et al
    Why Are CD8 T Cell Epitopes of Human Influenza A Virus Conserved?
    J Virol. 2019 Jan 9. pii: JVI.01534-18. doi: 10.1128/JVI.01534.
    PubMed     Text format     Abstract available

  15. TAY MZ, Kunz EL, Deal A, Zhang L, et al
    Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in HIV-1 Chronically Infected Women.
    J Virol. 2019 Jan 30. pii: JVI.02084-18. doi: 10.1128/JVI.02084.
    PubMed     Text format     Abstract available

  16. RIJAL P, Wang BB, Tan TK, Schimanski L, et al
    Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans.
    J Virol. 2019 Nov 20. pii: JVI.01182-19. doi: 10.1128/JVI.01182.
    PubMed     Text format     Abstract available

  17. SMITH A, Rodriguez L, Ghouayel ME, Nogales A, et al
    A live-attenuated influenza vaccine (LAIV) elicits enhanced heterologous protection when the internal genes of the vaccine are matched to the challenge virus.
    J Virol. 2019 Nov 20. pii: JVI.01065-19. doi: 10.1128/JVI.01065.
    PubMed     Text format     Abstract available


    JAMA

  18. KUEHN B
    Summit Leaders Urge Greater HPV Vaccination in Africa.
    JAMA. 2019;322:1853.
    PubMed     Text format    


    Lancet

  19. MAKRI A
    Progress lags on vaccines to beat antimicrobial resistance.
    Lancet. 2019;394:1793-1794.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  20. MATANOCK A, Lee G, Gierke R, Kobayashi M, et al
    Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >/=65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
    MMWR Morb Mortal Wkly Rep. 2019;68:1069-1075.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  21. CHURCH JA, Rogawski McQuade ET, Mutasa K, Taniuchi M, et al
    Enteropathogens and Rotavirus Vaccine Immunogenicity in a Cluster Randomized Trial of Improved Water, Sanitation and Hygiene in Rural Zimbabwe.
    Pediatr Infect Dis J. 2019;38:1242-1248.
    PubMed     Text format     Abstract available


    Pediatrics

  22. DONAHUE JG, Kieke BA, Lewis EM, Weintraub ES, et al
    Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.
    Pediatrics. 2019 Nov 18. pii: peds.2019-1808. doi: 10.1542/peds.2019-1808.
    PubMed     Text format     Abstract available

  23. MEISSNER HC
    From Peyton Rous to the HPV Vaccine: A Journey of Discovery and Progress.
    Pediatrics. 2019 Nov 18. pii: peds.2019-2345. doi: 10.1542/peds.2019-2345.
    PubMed     Text format    

  24. SHIMABUKURO TT, Su JR, Marquez PL, Mba-Jonas A, et al
    Safety of the 9-Valent Human Papillomavirus Vaccine.
    Pediatrics. 2019 Nov 18. pii: peds.2019-1791. doi: 10.1542/peds.2019-1791.
    PubMed     Text format     Abstract available


    PLoS One

  25. THIELMANN A, Puth MT, Kersting C, Porz J, et al
    Vaccine cold chain in general practices: A prospective study in 75 refrigerators (Keep Cool study).
    PLoS One. 2019;14:e0224972.
    PubMed     Text format     Abstract available


    Vaccine

  26. ZENG W, Horrocks KJ, Tan ACL, Wong CY, et al
    Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population.
    Vaccine. 2019 Nov 15. pii: S0264-410X(19)31435.
    PubMed     Text format     Abstract available

  27. INSULANDER M, Lindh G, Stenkvist J, Samuelson A, et al
    Long-term follow-up of a vaccination program for infants born to HBsAg-positive mothers in Stockholm County, Sweden.
    Vaccine. 2019 Nov 15. pii: S0264-410X(19)31502.
    PubMed     Text format     Abstract available

  28. WANG Y, Zhou Y, Zhang J, Wang X, et al
    iTRAQ-based proteomic analysis of Mycoplasma bovis NM-28 strain from two generations for vaccine screening.
    Vaccine. 2019 Nov 15. pii: S0264-410X(19)31441.
    PubMed     Text format     Abstract available

  29. FLOREK K, Mutschler J, McLean HQ, King JP, et al
    Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15.
    Vaccine. 2019 Nov 18. pii: S0264-410X(19)31440.
    PubMed     Text format     Abstract available

  30. TSUZUKI S, Baguelin M, Pebody R, van Leeuwen E, et al
    Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31508.
    PubMed     Text format     Abstract available

  31. WILKIE M, Satti I, Minhinnick A, Harris S, et al
    A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31504.
    PubMed     Text format     Abstract available

  32. RAFFERTY ERS, McDonald W, Osgood ND, Qian W, et al
    Seeking the optimal schedule for chickenpox vaccination in Canada: Using an agent-based model to explore the impact of dose timing, coverage and waning of immunity on disease outcomes.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31445.
    PubMed     Text format     Abstract available

  33. PATEL MM, Davis W, Beacham L, Spencer S, et al
    Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children - A systematic review and a meta-analysis.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31433.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: